PubMed Health⌕ Search

Biomedical subjects

E Ettedgui

Publications and source records attributed to E Ettedgui.

10 recordsLinked to original sources
PubMed1987

Plasma MHPG levels in lactate and isoproterenol anxiety states.

It has been claimed that an increase in brain noradrenergic activity plays a role in panic disorder and that enhanced noradrenergic activity may be reflected by plasma levels of MHPG. We investigated plasma MHPG levels in panic disorder patients at baseline and during lactate- and isoproterenol-induced anxiety states. These infusions and 5% dextrose infusions were given to 10 panic disorder patients and 9 healthy control subjects. Each subject received all three infusions, double-blind, in random order, and at 1-week intervals. When compared to controls, plasma free MHPG levels in panic patients were not elevated at baseline, during lactate or isoproterenol infusions, at the point of panic, or up to 20 min after the onset of panic. MHPG values were also not elevated in subjects who panicked compared to those who did not. MHPG values were significantly lower in three patients who failed to panic with isoproterenol, but the patient panickers had MHPG values similar to those of controls. Significant correlations between MHPG levels and anxiety ratings were infrequent and could be accounted for by chance alone. These results did not support the noradrenergic model for panic anxiety states induced by lactate or isoproterenol.

Adult↗
PubMed1985

Ambulatory monitoring of panic disorder.

Twelve patients with panic disorder and 11 control subjects received 24-hour ambulatory monitoring of heart rate, finger temperature, ambient temperature, and self-rated anxiety. No differences were found between groups in tonic levels of any measure or in their patterns of variation throughout the day. However, substantial heart rate increases and finger temperature changes did occur in panic attacks but not during control periods having equally high anxiety ratings. These measures may be useful in the diagnosis of panic disorder and in the assessment of treatment outcome.

Adult↗
PubMed1985

Cholinergic REM induction response: separation of anxiety and depression.

Five groups of subjects underwent EEG sleep recordings, arecoline rapid eye movement (REM) induction response testing, and Schedule for Affective Disorders and Schizophrenia (SADS) interview. Group I: 20 patients with primary major depressive disorder (MDD) (endogenous) without any coexisting anxiety disorder; Group II: 19 primary MDD (endogenous) patients with secondary panic, GAD, or phobic disorders; Group III: 18 patients with primary anxiety disorder without coexisting MDD; Group IV: 14 patients with primary anxiety plus secondary MDD; Group V: 26 normal controls. Modified Research Diagnostic Criteria (RDC) were used for diagnosis, based on the SADS interview. There was considerable overlap of SADS scaled scores between patient groups, which is consistent with a heterogeneous clinical presentation of depressive and anxiety states. REM latency was significantly shorter in patients with primary MDD (without anxiety) as compared with that in patients with primary anxiety (no MDD) and normals. Arecoline REM induction response time was significantly shorter in both primary affective groups (I and II) as compared with primary anxiety (no MDD) patients and normal controls. REM latency and arecoline REM induction time was not significantly different between the primary anxiety groups (III and IV) and normals. The study highlights the use of biological markers in differentiating between clinical syndromes confounded by mixed or overlapping phenomenology.

Adult↗
PubMed1985

Posttraumatic stress disorder.

The authors review posttraumatic stress disorder in terms of clinical features, historical development and phenomenology, and relationship to other psychiatric disorders. Treatment modalities are detailed.

Agoraphobia↗
PubMed1984

Psychophysiological factors in panic disorder.

Panic disorder patients were compared with normal subjects during intravenous infusion of sodium lactate, isoproterenol, and placebo. Panic attacks meeting the criteria of the Diagnostic and Statistical Manual, vol. 3 [American Psychiatric Association, 1980] occurred during all three conditions in patients and during the lactate and isoproterenol infusions in normals. Patients had significantly higher average levels of skin conductance, heart rate and state anxiety, and significantly lower finger temperatures compared to normal subjects. However, no measure reliably differentiated panic attacks from nonattack periods. It is concluded that the peripheral physiologic responses investigated are neither necessary nor sufficient for the occurrence of panic attacks. It is possible that reports of these attacks represent phobic responses to intense anxiety.

Anxiety Disorders↗
PubMed1984

A comparison of lactate and isoproterenol anxiety states.

Both sodium lactate and isoproterenol can produce anxiety symptoms in patients with panic attacks. We administered both substances intravenously under placebo-controlled, double-blind conditions to patients with panic attacks and normal control subjects. We measured changes in anxiety levels using the Hamilton Anxiety Scale, State-Trait Anxiety Inventory, and a Panic Severity Scale. Measurements of respiratory rate and blood pH, pO2, pCO2, HCO3, and base excess were used to determine the relationship of hyperventilation to the symptoms induced by the infusions. Heart rate, epinephrine and norepinephrine levels were measured to determine whether there are changes related to palpitations and chest pain. Finger temperature and galvanic skin response were monitored to see whether any changes correlate with subject reports of hot or cold flashes and sweating. In this presentation, we will describe the clinical and biochemical changes that occur during panic attacks.

Adult↗
PubMed1984

The beta-receptor: isoproterenol anxiety states.

To learn the effect of isoproterenol on patients meeting Research Diagnostic Criteria (RDC) for panic disorder, we administered isoproterenol, racemic sodium lactate, and glucose to them and to nonpsychiatric control subjects. Each subject received all 3 infusions, double-blind in random order. A 21-item self-rating panic scale was constructed from the RDC for panic disorder and was used to identify RDC panic attacks. The results of this study and the preliminary results from the infusions after treatment with imipramine are discussed in the text, and the results from the first patient to be reinfused after treatment are presented graphically.

Adolescent↗